Citadel Advisors’s Seagen Inc. Common Stock SGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,428,418
| Closed | -$515M | – | 15585 |
|
|
2023
Q3 | $515M | Buy |
2,428,418
+1,666,890
| +219% | +$333M | 0.11% | 98 |
|
|
2023
Q2 | $147M | Buy |
761,528
+377,582
| +98% | +$75M | 0.03% | 432 |
|
|
2023
Q1 | $77.7M | Buy |
383,946
+342,493
| +826% | +$54.9M | 0.02% | 762 |
|
|
2022
Q4 | $5.33M | Sell |
41,453
-538,224
| -93% | -$69.5M | ﹤0.01% | 3748 |
|
|
2022
Q3 | $79.3M | Sell |
579,677
-110,265
| -16% | -$18M | 0.02% | 737 |
|
|
2022
Q2 | $122M | Sell |
689,942
-68,676
| -9% | -$9.9M | 0.03% | 468 |
|
|
2022
Q1 | $109M | Sell |
758,618
-38,683
| -5% | -$5.23M | 0.02% | 615 |
|
|
2021
Q4 | $123M | Sell |
797,301
-439,538
| -36% | -$73.6M | 0.03% | 545 |
|
|
2021
Q3 | $210M | Sell |
1,236,839
-53,939
| -4% | -$8.39M | 0.04% | 325 |
|
|
2021
Q2 | $204M | Buy |
1,290,778
+1,058,266
| +455% | +$157M | 0.05% | 310 |
|
|
2021
Q1 | $32.3M | Buy |
232,512
+154,205
| +197% | +$24.8M | 0.01% | 1444 |
|
|
2020
Q4 | $13.7M | Sell |
78,307
-290,121
| -79% | -$54.1M | ﹤0.01% | 2237 |
|
|
2020
Q3 | $72.1M | Buy |
368,428
+311,019
| +542% | +$52.1M | 0.02% | 637 |
|
|
2020
Q2 | $9.76M | Sell |
57,409
-105,956
| -65% | -$15.8M | ﹤0.01% | 2245 |
|
|
2020
Q1 | $18.8M | Buy |
163,365
+127,374
| +354% | +$14.1M | 0.01% | 1281 |
|
|
2019
Q4 | $4.11M | Sell |
35,991
-481,527
| -93% | -$51.1M | ﹤0.01% | 3323 |
|
|
2019
Q3 | $44.2M | Buy |
517,518
+195,721
| +61% | +$14.3M | 0.02% | 830 |
|
|
2019
Q2 | $22.3M | Buy |
321,797
+270,766
| +531% | +$19M | 0.01% | 1333 |
|
|
2019
Q1 | $3.74M | Sell |
51,031
-1,148,887
| -96% | -$81.7M | ﹤0.01% | 3418 |
|
|
2018
Q4 | $68M | Buy |
+1,199,918
| New | +$75.3M | 0.04% | 478 |
|
|
2018
Q3 | – | Sell |
-1,333,126
| Closed | -$98.2M | – | 9831 |
|
|
2018
Q2 | $88.5M | Buy |
1,333,126
+374,461
| +39% | +$21.5M | 0.04% | 418 |
|
|
2018
Q1 | $50.2M | Sell |
958,665
-90,951
| -9% | -$4.96M | 0.03% | 599 |
|
|
2017
Q4 | $56.2M | Buy |
1,049,616
+163,848
| +18% | +$9.57M | 0.03% | 556 |
|
|
2017
Q3 | $48.2M | Sell |
885,768
-412,369
| -32% | -$21.1M | 0.04% | 566 |
|
|
2017
Q2 | $67.2M | Buy |
1,298,137
+1,271,578
| +4,788% | +$80.8M | 0.06% | 367 |
|
|
2017
Q1 | $1.67M | Sell |
26,559
-23,254
| -47% | -$1.45M | ﹤0.01% | 3283 |
|
|
2016
Q4 | $2.63M | Sell |
49,813
-1,096,454
| -96% | -$65.9M | ﹤0.01% | 2645 |
|
|
2016
Q3 | $61.9M | Buy |
1,146,267
+391,986
| +52% | +$18.6M | 0.06% | 302 |
|
|
2016
Q2 | $30.5M | Buy |
754,281
+737,145
| +4,302% | +$28M | 0.03% | 548 |
|
|
2016
Q1 | $601K | Sell |
17,136
-832,594
| -98% | -$28M | ﹤0.01% | 4148 |
|
|
2015
Q4 | $38.1M | Sell |
849,730
-2,572,571
| -75% | -$107M | 0.04% | 517 |
|
|
2015
Q3 | $132M | Buy |
+3,422,301
| New | +$154M | 0.13% | 147 |
|
|
2015
Q2 | – | Sell |
-59,465
| Closed | -$2.45M | – | 9186 |
|
|
2015
Q1 | $2.1M | Sell |
59,465
-1,120,516
| -95% | -$38.2M | ﹤0.01% | 3002 |
|
|
2014
Q4 | $37.9M | Buy |
+1,179,981
| New | +$41.1M | 0.04% | 600 |
|
|
2014
Q3 | – | Sell |
-70,776
| Closed | -$2.78M | – | 8494 |
|
|
2014
Q2 | $2.71M | Buy |
70,776
+55,413
| +361% | +$2.1M | ﹤0.01% | 2445 |
|
|
2014
Q1 | $700K | Sell |
15,363
-63,008
| -80% | -$3.01M | ﹤0.01% | 3890 |
|
|
2013
Q4 | $3.13M | Buy |
78,371
+49,361
| +170% | +$2.01M | ﹤0.01% | 2105 |
|
|
2013
Q3 | $1.27M | Sell |
29,010
-25,232
| -47% | -$1.05M | ﹤0.01% | 2855 |
|
|
2013
Q2 | $1.71M | Buy |
+54,242
| New | +$1.89M | ﹤0.01% | 2648 |
|
Other funds holding SGEN
SCM
IA
BTI
FBC
VWA
SAG
Citadel Advisors's SGEN Position: Q4 2023 in Review
Citadel Advisors sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 2,428,418 shares — an estimated $515M sold.
Citadel Advisors first reported a position in SGEN in Q2 2013 and held it in 39 quarters. The position peaked at $515M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.
- Citadel Advisors reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Citadel Advisors sold 2,428,418 Seagen Inc. Common Stock shares in Q4 2023, an estimated $515M.
- Citadel Advisors first reported a position in Seagen Inc. Common Stock in Q2 2013 and held it in 39 quarters.
- Citadel Advisors's Seagen Inc. Common Stock position peaked at $515M in Q3 2023.
- 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.